1. Opie, L. H., Commerford, P. J., Gersh, B. J., & Pfeffer, M. A. (2006). Controversies in ven- tricular remodelling. Lancet,
367, 356–367.
2. Kindo, M., Gerelli, S., Bouitbir, J., Charles, A-L., Zoll, J., Minh, TH., Monassier, L., Favret, F., Piquard, F., Geny, B. (2012) Pressure overload-induced mild cardiac hypertrophy reduces left ventricular trans mural differences in mitochondrial respiratory chain activity and increases oxidative stress. Frontiers in physiology, article 332.
3. Zhou, S., Liu, Y., Prater, K., Zheng, Y., & Cai, L. (2013). Roles of microRNAs in pressure overload- and ischemia-related myocardial remodeling. Life Sciences,
93(23), 855–862.
4. Elzenaar, I., Pinto, Y. M., & van Oort, R. J. (2013). MicroRNAs in heart failure: new targets in disease management. Clinical Pharmacology and Therapeutics,
94(4), 480–489.
5. He, F., Peng, F., Xia, X., Zhao, C., Luo, Q., Guan, W., et al. (2014). MiR-135a promotes renal fibrosis in diabetic nephropathy by regulating TRPC1. Diabetologia,
57(8), 1726–1736.